Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PPI: new strategies for GERD].

Etsuo Hoshino1, Akiyoshi Ishiyama, Tomohiro Tsuchida

  • 1Department of Internal Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 4, 2004
PubMed
Summary

Proton pump inhibitors (PPIs) are more effective than H2-receptor antagonists (H2RAs) for treating GERD by blocking acid production day and night. PPI therapy requires individualized dosing and may face challenges like nocturnal acid breakthrough.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharyngeal endoscopic submucosal dissection: detection, technique, and considerations for Western adoption.

iGIE : innovation, investigation and insights·2026
Same author

Phospholipid membrane interfaces and metal cations, Ca<sup>2</sup><sup>+</sup> and Cu<sup>2+</sup>, modulate insulin amyloid fibrillation.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Clinical Outcomes of Antrectomy for Patients With Multiple Type I Gastric Neuroendocrine Tumors: A Case Series.

DEN open·2026
Same author

A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2026
Same author

Treatment outcomes of low-radial-force self-expandable metal stent placement and palliative radiotherapy for unresectable advanced esophageal squamous cell carcinoma with dysphagia.

Esophagus : official journal of the Japan Esophageal Society·2026
Same author

Interfacial sequestration by phospholipid membranes and buffer-dependent dual pathways in heat-induced insulin fibrillation.

Colloids and surfaces. B, Biointerfaces·2026

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Gastroesophageal reflux disease (GERD) is commonly treated with medications.
  • Proton pump inhibitors (PPIs) are considered first-line therapy due to their efficacy.
  • H2-receptor antagonists (H2RAs) primarily suppress nocturnal gastric acid secretion.

Purpose of the Study:

  • To highlight the superior efficacy of PPIs over H2RAs in GERD management.
  • To explain the diagnostic utility of the PPI-test for GERD.
  • To outline optimal PPI dosing strategies, including initial and maintenance therapy.

Main Methods:

  • Comparative analysis of PPI and H2RA efficacy.
  • Description of the PPI-test as a diagnostic tool.
  • Explanation of individualized PPI dosing and titration techniques ('New Step-down therapy').

Related Experiment Videos

Main Results:

  • PPIs effectively block gastric acid production both day and night, unlike H2RAs.
  • The PPI-test reliably differentiates GERD from conditions with similar symptoms.
  • Initial GERD therapy should involve a full PPI dose, with maintenance doses individualized.

Conclusions:

  • PPIs are the preferred first-line treatment for GERD.
  • Individualized maintenance therapy with PPIs, using a step-down approach, is crucial.
  • Nocturnal acid breakthrough and rapid PPI metabolism (CYP2C19 extensive metabolizers) are potential causes of PPI resistance.